Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), High grade lymphoma, Leukaemia, Lymphoma, Non-Hodgkin lymphoma (NHL)
Closed
Phase 2
This trial is looking at acalabrutinib to see if it can improve treatment for people with Richter’s syndrome.
Chronic lymphocytic leukaemia (CLL) can sometimes develop into a condition called Richter’s syndrome. Richter's syndrome is a type of non-Hodgkin lymphoma (NHL).
Recruitment start: 23 July 2019
Recruitment end: 28 February 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Toby Eyre
Blood Cancer UK
Trials Acceleration Program (TAP)
Acerta Pharma
University of Birmingham
Last reviewed: 27 Feb 2026
CRUK internal database number: 16164
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
